| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biomedical Sciences, Creighton University School of Medicine (U.A., R.D.R., T.E.A.), Omaha, Nebraska 68178; Research Service (151), Department of Veteran Affairs Medical Center (R.D.R.), Omaha, Nebraska 68105; and Arvid Wretlind Laboratory for Metabolic Research, Department of Surgery, Karolinska Institutet at Huddinge University Hospital (U.A., J.P., J.L., C.A.), S-141 86 Huddinge, Sweden
Address all correspondence and requests for reprints to: Johan Permert, M.D., Ph.D., Department of Surgery, Karolinska Institutet at Huddinge University Hospital, S-141 86 Huddinge, Stockholm, Sweden. E-mail: Johan.Permert{at}karo.ki.se
Islet amyloid polypeptide (IAPP) is a 37-amino acid polypeptide coproduced with insulin in the ß-cells of the pancreatic islets. The physiological effects of IAPP have not been established. Although effects on glucose metabolism are seen only at pharmacological doses both in vitro and in vivo, effects on food intake have been shown at near-physiological concentrations. The aim of the present study was to investigate the effects of similar elevations of circulating plasma IAPP levels on glucose metabolism in rats and to evaluate the function of a novel aortic catheterization technique.
In a cross-over design, two sets of experiments in which conscious unrestrained rats received chronic IAPP infusions at 0 and 2 or 0 and 7 pmol/kg·min were performed. Peripheral glucose disposal was determined by means of the hyperinsulinemic euglycemic clamp technique. Chronic elevations of circulating IAPP at concentrations that reduced food intake [43.5 ± 6.2 g (control) vs. 35.7 ± 8.2 g (IAPP; P < 0.01) and 34.0 ± 2.2 g (control) vs. 28.8 ± 1.4 g (IAPP; P = 0.07) for the 7 and 2 pmol/kg·min experiments, respectively] had no effect on the glucose metabolic rate [GMR; 18.5 ± 0.6 mmol/kg·h (control) vs. 18.7 ± 0.9 mmol/kg·h (IAPP) and 14.4 ± 0.7 mmol/kg·h (control) vs. 15.6 ± 0.7 mmol/kg·h (IAPP) for the 7 and 2 pmol/kg·min experiments, respectively]. Thus, effects on glucose metabolism are unlikely to explain the anorectic effect of IAPP.
This article has been cited by other articles:
![]() |
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis Endocr. Rev., May 1, 2008; 29(3): 303 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R39 - R46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Reidelberger, D. A. Castellanos, and M. Hulce Effects of peripheral CCK receptor blockade on food intake in rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R429 - R437. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Havel Peripheral Signals Conveying Metabolic Information to the Brain: Short-Term and Long-Term Regulation of Food Intake and Energy Homeostasis Experimental Biology and Medicine, December 1, 2001; 226(11): 963 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Arnelo, R. Reidelberger, T. E. Adrian, J. Larsson, and J. Permert Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1537 - R1542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |